论文部分内容阅读
To estimate the risk of and risk factors for progression among human immunodeficiency virus (HIV)- seropositive women with abnormal cervical cytology but negative colposcopy. Methods: In a prospective cohort study, 391 HIV- seropositive and 103 seronegative women with cervical cytology read as atypical squamous cells (ASC) or low-grade squamous intraepithelial lesion (LSIL) but negative colposcopy were followed up for a mean of 4.0 years with cytology at 6 month intervals. Colposcopy was prescribed for any epithelial abnormality. Results: Progression to CIN2, CIN3, high-grade SIL/severe dysplasia, or cancer occurred in 47 (12% ) HIV seropositive women and 4 (4% ) HIV- seronegative women (P = .02). Progression to CIN1 was seen in an additional 12 HIV seropositive women and 1 seronegative woman. In multivariate analysis, high-risk but not low-risk HPV detection (hazard ratio [HR] 2.46- 95% confidence interval [CI] 1.18- 5.12, P = .02 for high risk, HR 1.41, 95% CI 0.62- 3.21, P = .42 for low risk), satisfactory colposcopy (HR 2.01, 95% CI 1.11- 3.65, P = .02), and non-Hispanic African-American ethnicity (HR 5.08, 95% CI 1.72- 14.98, P = .003) were the only factors associated with progression, while HIV serostatus was marginally significant (HR 2.53, 95% CI 0.85- 7.50, P = .09). Conclusion: Human immunodeficiency virus- seropositive women with negative colposcopy after borderline cytology face a higher risk of progression than seronegative women, but the absolute risk is low and becomes nonsignificant after controlling for HPV risk type, ethnicity, and colposcopic findings. Observation is appropriate.
To estimate the risk of and risk factors for progression among human immunodeficiency virus (HIV) - seropositive women with abnormal cervical cytology but negative colposcopy. Methods: In a prospective cohort study, 391 HIV-seropositive and 103 seronegative women with cervical cytology read as atypical Colposcopy was prescribed for any epithelial abnormality. Results: Progression to CIN2, CIN3, High-grade SIL / severe dysplasia, or cancer occurred in 47 (12%) of HIV seropositive women and 4 (4%) of HIV-seronegative women (P = .02). Progression to CIN1 was seen in an additional 12 HIV seropositive women and 1 seronegative woman. In multivariate analysis, high-risk but not low-risk HPV detection (hazard ratio 2.46-95% confidence interval [CI] 1.18-5.12, P = .02 for high risk, HR 1.41, 95% CI 0.62- 3.21, P = .42 for low risk), satisfactory colposcopy (HR 2.01, 95% CI 1.11-3.65, P = .02), and non-Hispanic African-American ethnicity (HR 5.08, 95% CI 1.72-14.98, P = .003) were the only Factors associated with progression, while HIV serostatus was marginally significant (HR 2.53, 95% CI 0.85-7.50, P = .09). Conclusion: Human immunodeficiency virus- seropositive women with negative colposcopy after borderline cytology face a higher risk of progression than seronegative women, but the absolute risk is low and becoming nonsignificant after controlling for HPV risk type, ethnicity, and colposcopic findings. Observation is appropriate.